Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 21;113(10):1548-1561.e8.
doi: 10.1016/j.neuron.2025.04.030.

Machine learning identification of enhancers in the rhesus macaque genome

Affiliations

Machine learning identification of enhancers in the rhesus macaque genome

Jing He et al. Neuron. .

Abstract

Nonhuman primate (NHP) neuroanatomy and cognitive complexity make NHPs ideal models to study human neurobiology and disease. However, NHP circuit-function investigations are limited by the availability of molecular reagents that are effective in NHPs. This calls for reagent development approaches that prioritize NHPs. Therefore, we derived enhancers from the NHP genome. We defined cell-type-specific open chromatin regions (OCRs) in single-cell data from rhesus macaques. We trained machine-learning models to rank those OCRs according to their potential as cell-type-specific enhancers for cells in the dorsolateral prefrontal cortex (DLPFC). We packaged the top-ranked layer-3-pyramidal-neuron enhancer into AAV and injected it into the macaque DLPFC. Expression was mostly restricted to layers 2 and 3 and confirmed with light-driven activation of channelrhodopsin. These results provide a crucial tool for studying the causal functions of DLPFC and provide a roadmap for optimized gene delivery in primates.

Keywords: AAV; DLPFC; cell types; cell-type-specific; cognition; dorsolateral prefrontal cortex; enhancer; machine learning; optogenetics; rhesus monkey.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.H., B.N.P., L.C.B., W.R.S., and A.R.P. are inventors on AAV patent applications. L.C.B. is a co-founder of Avista Therapeutics and VegaVect. M.S. is an employee of Avista Therapeutics. A.R.P. is founder and CEO of Snail Biosciences. A.R.P. and B.N.P. have Snail Biosciences stockholdings.

MeSH terms